Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06816823 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 4, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 10 wordsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jun 2025 to Sep 2025
    • Start date changed from estimate of Feb 2025 to Apr 7, 2025
    • Site details revised
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-center, open-label, first-in-human, dose-escalation study in patients with pancreatic cancer.
Trial Details
NCT Number NCT06816823
Lead Sponsor Changhai Hospital
Conditions
(from sponsor)		 Pancreatic Cancer
Related terms Pancreatic Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov